IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ligand Pharmaceuticals Inc CON

CUSIP: 532CNT011 | 1 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Sterling Capital Management LLC23
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Sterling Capital Management LLC
23$00.0%CoreMediumCharlotte, NC2026-10-22